PBMs have notoriously been a black box of pricing, but that's starting to change. Check out APC's upcoming CE webinar (next Tuesday!), "State and Federal Regulation of PBMs – Legislative and Regulatory Efforts to Open the Black Box of PBMs."
2021 has new opportunities for you to serve and advance your profession. Lend your expertise as a member of a 2020 APC volunteer committee, the workhorses of the alliance — help develop programming, chase possibilities, recommend policy, and more.
A big thank you to the 32 members of Congress who signed a letter to FDA Commissioner Stephen Hahn — a letter urging that the agency not base decisions about compounded hormone therapy on the flawed NASEM study.
Paper prescriptions are well on their way out, so your e-script knowledge needs to be 100 percent up to date. NCPDP Script 2017071 is the 800-pound gorilla of electronic prescribing, and you’ll want to know it backwards and forwards. APC’s new live webinar, E-Prescribing in Compounding, will help you do just that.
Why we need to use the evidence
Working for more reasonable FDA guidance
Bad for states, bad for compounders, bad for patients
Fighting the Tricare/ESI Recoupment
December 8 — Live CE Webinar: “State and Federal Regulation of PBMs: Legislative and Regulatory Efforts to Open the Black Box of PBMs and Bring Transparency and Equity to Independent Pharmacies.“; 2:00 to 3:00 pm EST
December 15 — Live CE Webinar: “E-Prescribing in Compounding“; 2:00 to 3:00 pm EST
And then there’s all this…
Ads or information or a little of both. The sky’s the limit. Maybe. At least the front door.
